TLTrident Lifeline543616Subsidiary or JV

Subsidiary makes private placement of equity shares; holding in it now stands at 58.23%

Trident Mediquip Limited, a subsidiary, has made a private placement of equity shares to other shareholders.

By ScoutQuest · Thu 15 Oct 2026, 6:06 PM IST · 2 min read

Holding in subsidiary post allotment

58.23%

Holding in subsidiary pre allotment

59.67%

Subsidiary turnover FY 2025-26

Rs. 27.31 Cr

What the update says

• Trident Mediquip Limited (TML), a subsidiary, has made a private placement of equity shares to other shareholders.
• Following that allotment to other shareholders, the shareholding of the listed company in TML stands at 58.23%.
• The pre-allotment holding in TML was 59.67%, so the stake has moved down from 59.67% to 58.23%.
• TML continues to be a subsidiary of the company, with the company's stake above half of its equity.

Who the other allottees are

• The update states the transaction falls within related party transaction(s).
• Mr. Amit Bhupendra Halvawala and Mr. Chetan Chandrakant Jariwala (director's relative of Rupaben Jariwala) are member cum Director, and Mr. Hardik Jigishkumar Desai is a member.
• The update says all of them are part of the promoters/promoter group/board of the acquiring company, i.e. the listed company, and that the transaction is being undertaken on an arm's length basis.

What we know about the subsidiary

• Name: Trident Mediquip Limited, a company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat.
• Date of incorporation: October 19, 2019.
• Product/line of business: medical device industry. Presence of the entity: India.
• Authorised share capital: Rs. 11,00,00,000/- divided into 1,10,00,000 equity shares of Rs.10/- each.
• Paid-up share capital: Rs. 10.25 crore divided into 1,02,46,980 equity shares of Rs.10/- each.
• Turnover: Financial year 2023-24 20.58 Cr; Financial Year 2024-25 21.29 Cr; Financial Year 2025-26 27.31 Cr.

How to read this

• A private placement means fresh equity shares are issued to shareholders other than the parent. The total number of shares goes up, so the parent's percentage holding comes down even though it has not sold any shares.
• Here the listed company's stake in TML moves from 59.67% to 58.23%. Since it stays above 50%, TML remains a subsidiary.
• The update classifies the transaction as a related party transaction and says it is on an arm's length basis. The allottees named in the update belong to the promoter/promoter group/board of the acquiring company, a point investors may track when following group-level shareholding.
• The subsidiary operates in medical devices, and the turnover stated in the update has moved from 20.58 Cr (FY 2023-24) to 21.29 Cr (FY 2024-25) to 27.31 Cr (FY 2025-26).

What to take away

• This is a change in the listed company's ownership percentage in its subsidiary after a private placement of shares by that subsidiary.
• The listed company's holding remains a majority stake in TML at 58.23%.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev